Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.

Diabetes care

Volumn 31 Suppl 2, Issue , 2008, Pages

  Lewis, Edmund J ^a   Xu, Xiulong ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARAN SULFATE; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN;

BASEMENT MEMBRANE; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULUS; HUMAN; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; REVIEW; UROTHELIUM;

ANTICOAGULANTS; BASEMENT MEMBRANE; DIABETIC NEPHROPATHIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARINOIDS; HEPARITIN SULFATE; HUMANS; KIDNEY GLOMERULUS; PERMEABILITY; UROTHELIUM;

MLCS; MLOWN;

EID: 41149087185     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-s251     Document Type: Review

References (61)